Study S001609

A Phase II, Randomized Open-label, Multicenter Study to Evaluate the Efficacy and Safety of BGM0504 Compared to Tirzepatide in Adults Who Have Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06911203
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 96
Start: 2025-04-09
Primary completion: 2026-01-14
Lead sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Conditions: Obesity
Interventions: DRUG:BGM0504; DRUG:Tirzepatide
Results posted: FALSE

Registered primary outcomes

Change From Baseline in Body Weight [Week 0, Week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.